Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
This study is currently recruiting participants.
Study NCT00001645   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: February 28, 2009   History of Changes

November 3, 1999
February 28, 2009
March 1997
 
 
 
Complete list of historical versions of study NCT00001645 on ClinicalTrials.gov Archive Site
 
 
 
Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection

The purpose of this study is to evaluate, treat and follow patients with parasitic infections.

People with a known or suspected parasitic infection who are at least 1 year old may be enrolled. This study does not involve any experimental treatments.

Participants will have a physical examination and laboratory tests on blood, stool, or urine. Blood samples may be collected at regular intervals, but no more than 450 ml (15 ounces) of blood will be drawn from adults, and no more than 7 ml (1-1/2 teaspoons) per kg (2.2 pounds) of body weight from children, in any 6-week period. Other tests may include x-rays, electrocardiogram (EKG), or tissue biopsy (surgical removal of a small tissue sample), depending on the individual's condition.

Patients may be offered treatment or may be referred to another study that is more appropriate for the problem. Any treatment provided in this study will be according to standard medical practice for the patient's specific medical problem. Patients' responses to treatment will be evaluated at regularly scheduled clinic visits. The length of time between visits and the total duration of the study for a given individual will be determined by the study doctor, based on that person's medical condition.

This study is designed as a prospective study to evaluate and treat patients with parasitic infection. Up to 300 patients with known or suspected parasitic infection will be enrolled and will be evaluated for the presence of a parasitic infection. Minimal studies scheduled for each visit will include a medical history, physical examination, routine laboratory tests and specialized diagnostic procedures for possible parasitic infections. Treatment plans will be individualized for each patient's particular condition, and the number and length of additional visits and diagnostic evaluations will vary accordingly. Specific treatment regimens will be in accordance with standard medical practice.

 
Observational
 
  • Chagas Disease
  • Malaria
  • Parasitic Disease
  • Trypanosomiasis
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
300
 
 
  • INCLUSION CRITERIA:

Age 1 or over.

Access to a primary medical care provider outside of the NIH.

Ability to give written informed consent (for adults) and parental consent (for those under 18).

Clinical evidence suggestive of a parasitic infection.

EXCLUSION CRITERIA:

Less than 1 year of age.

No evidence suggestive of a parasitic infection.

Both
1 Year to 75 Years
No
Contact: Patient Recruitment and Public Liaison Office (800) 411-1222 prpl@mail.cc.nih.gov
Contact: TTY 1-866-411-1010
United States
 
NCT00001645
 
970096, 97-I-0096
National Institute of Allergy and Infectious Diseases (NIAID)
 
 
National Institutes of Health Clinical Center (CC)
January 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP